Sanofi SA (ADR)  

(Public, NYSE:SNY)   Watch this stock  
Find more results for SNY
38.35
0.00 (0.00%)
Pre-market: 38.06 -0.29 (-0.76%)
Sep 26, 8:59AM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 37.41 - 51.88
Open     -
Vol / Avg. 12,460.00/2.16M
Mkt cap 98.32B
P/E 21.51
Div/yield 1.66/4.34
EPS 1.78
Shares 1.29B
Beta 0.97
Inst. own 20%

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 11.82% 13.01%
Operating margin 17.14% 15.99%
EBITD margin - 31.94%
Return on average assets - 4.54%
Return on average equity - 7.73%
Employees 115,631 -
CDP Score - 99 B

Address

54 rue la Boetie, Paris 8
PARIS, 75008
France
+33-1-53774000 (Phone)
+33-1-53774463 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation. Its pharmaceuticals portfolio consists of products and a range of prescription medicines, generic medicines and consumer health products. The Vaccines segment is dedicated to vaccines, including research, development, production and marketing. The Animal Health segment includes the research, development, production and marketing activities of Merial, which offers a range of medicines and vaccines for a range of animal species. It also operates in the Other segment, which includes the effects of retained commitments in respect of divested activities.

Officers and directors

Serge Weinberg Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Olivier Brandicourt Chairman of the Executive Committee, Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
Jerome Contamine Executive Vice President, Chief Financial Officer, Member of the Executive Committee and the Senior Leadership Team
Age: 58
Bio & Compensation  - Reuters
Karen Marie Linehan Executive Vice President, Legal Affairs and General Counsel, Member of the Executive Committee and the Senior Leadership Team
Age: 57
Bio & Compensation  - Reuters
Olivier Charmeil Executive Vice President and General Manager, General Medicines & Emerging Markets, Member of the Executive Committee and the Senior Leadership Team
Age: 53
Bio & Compensation  - Reuters
Peter Guenter Executive Vice President and General Manager, Diabetes & Cardiovascular, Member of the Executive Committee and the Senior Leadership Team
Age: 54
Bio & Compensation  - Reuters
Carsten Hellmann Executive Vice President and General Manager of Merial, Member of the Executive Committee and the Senior Leadership Team
Age: 52
Bio & Compensation  - Reuters
David Loew Executive Vice President and General Manager of Sanofi Pasteur, Member of the Executive Committee and the Senior Leadership Team
Bio & Compensation  - Reuters
David P. Meeker M.D. Executive Vice President and General Manager of Sanofi Genzyme, Member of the Executive Committee and the Senior Leadership Team
Bio & Compensation  - Reuters
Roberto Pucci Executive Vice President, Human Resources, Member of the Executive Committee and the Senior Leadership Team
Age: 52
Bio & Compensation  - Reuters